Uremic toxins impair human bone marrow-derived mesenchymal stem cells functionality in vitro

Area of Science:

• Cell Biology
• Nephrology
• Regenerative Medicine

Background:

• Mesenchymal stem cells (MSCs) show therapeutic promise for renal diseases.
• The impact of uremia on MSC functionality remains largely unknown.
• Uremic toxins, such as p-cresol (PC) and indoxyl sulfate (IS), accumulate in chronic kidney disease (CKD).

Purpose of the Study:

• To investigate the in vitro effects of uremic toxins (PC and IS) on human bone marrow-derived MSCs.
• To assess the influence of these toxins on MSC viability, proliferation, apoptosis, membrane integrity, and secretory properties.

Main Methods:

• MSCs were exposed to PC and IS at concentrations mimicking CKD stages.
• Cell viability assessed via MTT and BrdU assays.
• Apoptosis (Annexin V) and membrane damage (LDH) were measured.
• Secretory profiles analyzed by ELISA for cytokines and growth factors (VEGF, TGF-β1, IGF-1, IL-8).

Main Results:

• Uremic toxin concentrations significantly inhibited MSC metabolic activity and proliferation.
• Toxins did not induce apoptosis but caused cell membrane damage.
• MSC paracrine function was altered: decreased VEGF and TGF-β1, increased IGF-1 and IL-8 secretion.

Conclusions:

• Uremic toxins exert detrimental effects on human bone marrow-derived MSC functionality.
• The compromised function raises concerns about using autologous MSCs for kidney disease treatment.
• Further research is needed to validate MSC therapies in the context of uremia and CKD prevalence.